Blog

Bleeding risk in ET patients with extreme thrombocytosis

Photo of Rathnam Venkat/crunchbase.com

Oct 4, 2024, 15:11

Bleeding risk in ET patients with extreme thrombocytosis

Joan How, Hematologist and Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared an article by Rathnam K Venkat on X:

“Congrats to our wonderful medical student Rathnam for his article on bleeding risk in ET patients with extreme thrombocytosis – available online.

Tittle: Risk of Bleeding in Essential Thrombocythemia Patients with Extreme Thrombocytosis

Authors: Rathnam K Venkat, Robert A Redd, Amyah C. Harris, Martin J Aryee, Anna E. Marneth, Baransel Kamaz, Chulwoo J Kim, Mohammed Wazir, Lachelle D. Weeks, Maximilian Stahl, Daniel J DeAngelo, R. Coleman Lindsley, Marlise R. Luskin, Gabriela S Hobbs and Joan How.

Source: Joan How/X

Amyah C. Harris bleeding risk cancer ET patients Gabriela S Hobbs Joan How Marlise R. Luskin Martin J Aryee OncoDaily Oncology R. Coleman Lindsley Rathnam K Venkat Robert A Redd thrombocytosis

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot